Trinity Officially Launched its FDA-approved Preeclampsia Testing Service Announcement Trinity Biotech plc, a leading commercial-stage biotechnology company targeting diabetes management solutions and human diagnostics, and wearable biosensors, has officially launched a new testing service for...
Reshape’s Shareholders Cleared the Required Approvals to Officialize the Merger with Vyome Announcement Reshape Lifesciences shareholders ticked all proposals required for the completion of the previously introduced alliance with Vyome Therapeutics. The partnership will be officially eff...
IAQ is a Game-changer in the Healthcare Market Challenges in Healthcare Most of the outpatient facilities and hospitals are under pressure to cut costs while enhancing patient outcomes. Most of the facilities still approach the outdated systems; the serious and overlooked factors are highlight...
The global lyophilized injectable drugs market size is anticipated to reach USD 1,330.78 billion by 2034, increasing from USD 397.17 billion in 2025. The market is expected to grow at a CAGR of 14.40% from 2025 to 2034. Global Outlook The global lyophilized injectable drugs market is evolving ra...
Ingersoll Rand to Rule Globally with its Life Sciences Portfolio Announcement Ingersoll has acquired Ireland-based Dave Barry Plastics, which is a long-experienced and skilled manufacturer of plastic products for healthcare companies and life sciences. The acquisition demonstrates the company'...
MannKind and Blackstone to Initiate a Financing Agreement Announcement MannKind Corporation is a pioneer in the development and commercialization of inhaled therapeutic products and device delivery systems for patients with endocrine and orphan lung diseases. MannKind’s funds are managed...
Cognizant’s New TriZetto® AI Announcement Cognizant introduced a new Trizetto AI gateway is a foundational product launched to easily merge generative AI capabilities into its Trizetto healthcare ecosystem. This is a new, excellent solution focused on evolving healthcare delivery by ...
Freenome’s Licensing Agreement with Exact Sciences to Introduce a New Test for Colorectal Cancer Announcement Freenome, a leading biotechnology company developing an early cancer detection platform, has entered a licensing agreement with Exact Sciences to elevate its marketization of its...
AI’s support to pharma companies to handle policy pressures Announcement The previous experience, spanning years and months, created a regulatory storm for the biopharma industry. Companies have largely obeyed executive orders this year. The tariff policies and the Inflation Reduction Ac...
Porosome’s findings discovered an advancement, transforming AD research and treatment Announcement Porosome Therapeutics introduced major advancements in its excellent disease-modifying neurological platform. The new advancement will transition alzheimer’s disease (AD) treatment and...
